Keywords
PCI
Sarkubatrovalsartan
Cardiac function
Submitted : 2025-06-11
Accepted : 2025-06-26
Published : 2025-07-11
Abstract
Objective: To study the clinical value of sacubatravalsartan in patients with acute anterior myocardial infarction (AAMI) after percutaneous coronary intervention (PCI). Methods: 124 patients with AAMI from April 2022 to June 2024 were randomly divided into study group (56 cases) and control group (68 cases). Both groups were given aspirin during the treatment, the control group was given enalapril after operation, and the study group was given sacubatravalsartan after operation, both of which were treated for 2 months. Before and after treatment, CRP, IL-6, TNF - α, Hcy, BNP and other serological indicators were detected, HR, LVEDd, LVEF and other cardiac function indexes were detected, and postoperative complications and adverse drug reactions were compared between the two groups. Results: before treatment, there was no significant difference in each index level between the two groups (P > 0.05); after treatment, CRP, IL-6, TNF - α, Hcy, BNP, HR and LVEDd in the study group were lower than those in the control group (P < 0.05), and LVEF was higher than that in the control group (P < 0.05); the incidence of postoperative complications in the study group was lower than that in the control group (P < 0.05); there was no significant difference in the total adverse reaction rate between the two groups (P > 0.05). Conclusion: sacubatrovalsartan can effectively improve the cardiac function of patients with AAMI after PCI, reduce the incidence of postoperative complications, and has high safety.
References
Lippolis A, Buzzi P, Romano I, et al., 2019, Unexpected Reappearance of ST Elevation in the Anterior Precordial Leads Shortly After an Acute Anterior Myocardial Infarction. Journal of Electrocardiology, 52(6): 75–78.
Li D, Zhang G, Zhang M, et al., 2018, Study on the Effect of Nicorandil on No-Reflow in Coronary Arteries Before Acute Anterior Myocardial Infarction Surgery. Chinese Journal of Cardiovascular Rehabilitation Medicine, 27(2): 160–163.
Li J, Chen H, Chai Q, et al., 2020, The Effect of Sacubitril/Valsartan on Cardiac Function After Emergency Coronary Intervention for Acute Myocardial Infarction. Chinese Journal of Clinical Research, 33(9): 1200–1203.
Zan W, Yan P, Li Y, et al., 2018, The Effect of PCI Treatment on NYHA Cardiac Function Classification in Patients with Chronic Heart Failure Due to Coronary Heart Disease. Guizhou Medical Journal, 42(7): 806–807.
Liu L, Wang X, 2016, Emergency Treatment of Acute Myocardial Infarction. Chinese Journal for Clinicians, 44(2): 10–13.
Wei M, Zheng M, Liu G, et al., 2019, Effects of New Active Peptide on Heart Rate Variability and Cardiac Function in Patients with Acute Anterior Myocardial Infarction Undergoing Emergency PCI. Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, 17(6): 876–878.
Gulinal B, Ma Y, Zheng Y, et al., 2018, The Impact of the Establishment of a Chest Pain Center on the Diagnosis and Treatment Trends of Acute Anterior Myocardial Infarction. Journal of Xinjiang Medical University, 41(12): 7–10 + 16.
Gao H, Chen H, Guo C, et al., 2018, The Effect of Early T-Wave Inversion After Emergency Coronary Intervention for Acute Anterior Myocardial Infarction on Prognosis. Journal of Cardiopulmonary Vascular Diseases, 37(8): 743–746.
Zhang Q, Wang C, Shi S, et al., 2019, Relationship Between Left Ventricular Thrombus Formation and Adverse Outcomes in Patients with Acute Anterior Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention. Clinical Cardiology, 42(1): 69–75.
Yan M, Liu Q, Jiang Y, et al., 2020, Evaluation of Serum Vaspin and IL-6 Levels on Left Ventricular Remodeling After Acute Myocardial Infarction. Progress in Modern Biomedicine, 20(10): 1858–1863.
Claeys M, Coussement P, Dubois P, et al., 2019, Clinical Effects of Cyclosporine in Acute Anterior Myocardial Infarction Complicated by Heart Failure: A Subgroup Analysis of the CIRCUS Trial. American Heart Journal, 216: 147–149.
Chen Z, Zhang L, Huang X, et al., 2019, Relationship Between IL-6, Cys-C, Hcy, and Acute Myocardial Infarction. Prevention and Treatment of Cardio-/Cerebrovascular Diseases, 19(4): 347–348 + 351.
Li B, Li Y, Ma J, et al., 2019, Relationship Between ADAMTS-1 Expression Level and Acute Myocardial Infarction Area and Cardiovascular Outcomes. Journal of Practical Medicine, 35(7): 1088–1091.
Xiong Z, Man W, Li Y, et al., 2020, Clinical Efficacy of Sacubitril/Valsartan in Patients with Heart Failure After Myocardial Infarction. Heart Journal, 161(1): 34–38.
Chen C, Qian W, Ding H, et al., 2019, The Effect of Sacubitril/Valsartan on the Short-Term Prognosis of Patients with Acute Anterior Myocardial Infarction After Emergency PCI Surgery Complicated by Cardiac Insufficiency. Progress in Modern Biomedicine, 19(19): 3720–3725.